Stock IIQ INOVIQ LTD
Add to a list
To use this feature you must be a member
Log inSign up

Financials INOVIQ Ltd

Equities

IIQ

AU0000196149

Biotechnology & Medical Research

Delayed Australian S.E.
Other stock markets
 01:03:58 2024-04-29 am EDT 		5-day change 1st Jan Change
0.53 AUD +0.95% Intraday chart for INOVIQ Ltd 0.00% -20.30%
Apr. 19 INOVIQ Concludes Analytical Validation for Ovarian Cancer Blood Test MT
Apr. 15 Fears of Middle East Conflict Escalation Quell Appetite for Australian Shares MT

Valuation

Fiscal Period: Juni 2023 2024 2025 2026
Capitalization 1 78.22 48.31 - -
Enterprise Value (EV) 1 78.22 41.21 38.91 37.81
P/E ratio -8.72 x -5.65 x -11.7 x -
Yield - - - -
Capitalization / Revenue - 30.2 x 7.55 x 3.61 x
EV / Revenue - 25.8 x 6.08 x 2.82 x
EV / EBITDA - -5.72 x -10.5 x 34.4 x
EV / FCF - -5.35 x -9.98 x 42 x
FCF Yield - -18.7% -10% 2.38%
Price to Book - 2.63 x 2.63 x 2.63 x
Nbr of stocks (in thousands) 92,019 92,019 - -
Reference price 2 0.8500 0.5250 0.5250 0.5250
Announcement Date 8/29/23 - - -
1AUD in Million2AUD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Juni 2023 2024 2025 2026
Net sales 1 - 1.6 6.4 13.4
EBITDA 1 - -7.2 -3.7 1.1
EBIT 1 - -8.5 -5 -
Operating Margin - -531.25% -78.12% -
Earnings before Tax (EBT) 1 - -8.5 -5 -
Net income 1 -8.969 -8.5 -5 -
Net margin - -531.25% -78.12% -
EPS 2 -0.0975 -0.0930 -0.0450 -
Free Cash Flow 1 - -7.7 -3.9 0.9
FCF margin - -481.25% -60.94% 6.72%
FCF Conversion (EBITDA) - - - 81.82%
FCF Conversion (Net income) - - - -
Dividend per Share - - - -
Announcement Date 8/29/23 - - -
1AUD in Million2AUD
Estimates

Balance Sheet Analysis

Fiscal Period: June 2023 2024 2025 2026
Net Debt 1 - - - -
Net Cash position 1 - 7.1 9.4 10.5
Leverage (Debt/EBITDA) - - - -
Free Cash Flow 1 - -7.7 -3.9 0.9
ROE (net income / shareholders' equity) - - - -
ROA (Net income/ Total Assets) - - - -
Assets 1 - - - -
Book Value Per Share 2 - 0.2000 0.2000 0.2000
Cash Flow per Share 2 - -0.0600 -0.0300 -
Capex 1 - 0.5 0.2 0.2
Capex / Sales - 31.25% 3.12% 1.49%
Announcement Date 8/29/23 - - -
1AUD in Million2AUD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
INOVIQ LTD Stock INOVIQ Ltd
-20.30% 31.51M
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.51% 42.75B
LONZA GROUP AG Stock Lonza Group AG
+49.22% 41.61B
MODERNA, INC. Stock Moderna, Inc.
+8.57% 41.34B
CELLTRION, INC. Stock Celltrion, Inc.
-12.36% 26.59B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+8.92% 25.49B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-25.13% 18.12B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.17% 12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.12% 11.76B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.35% 11B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. IIQ Stock
  4. Financials INOVIQ Ltd